Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 2,552 shares of the company on April 23, 2024, according to a recent SEC Filing.
Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, has reported an insider sale according to a recent SEC filing.
Agios Pharmaceuticals Inc (NASDAQ:AGIO), a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and rare genetic diseases, has seen a recent insider transaction according to the latest SEC filings.
Carman Wenkoff, Executive Vice President & Chief Information Officer of Dollar General Corp (NYSE:DG), has sold 5,909 shares of the company on April 4, 2024, according to a recent SEC Filing.